2015
DOI: 10.1155/2015/321682
|View full text |Cite
|
Sign up to set email alerts
|

Application of Intrawound Vancomycin Powder during Spine Surgery in a Patient with Dialysis-Dependent Renal Failure

Abstract: Surgical site infections (SSIs) after spinal surgery are a serious complication that can be minimized with prophylaxis. Vancomycin is a common agent used in the prevention of SSI. Given that vancomycin is renally cleared, its use requires careful observation in dialysis-dependent patients due to toxicity at supratherapeutic levels. Since minimum inhibitory concentrations (MICs) for vancomycin have increased due to the emergence of resistant pathogens, the use of vancomycin in such patients is further complicat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 60 publications
0
1
0
Order By: Relevance
“…32 Subsequently, it has been proposed that topical vancomycin may be a safe alternative for SSI prophylaxis in the setting of patients with end-stage renal disease on dialysis. 33 There are limited data to suggest a quantified upper limit for safe application of tobramycin powder topically, although, there have been case reports of acute renal failure after intrawound tobramycin administration. 2,15,20 The most significant limitations of this study are the retrospective design and small sample size inherent to infection research.…”
Section: Discussionmentioning
confidence: 99%
“…32 Subsequently, it has been proposed that topical vancomycin may be a safe alternative for SSI prophylaxis in the setting of patients with end-stage renal disease on dialysis. 33 There are limited data to suggest a quantified upper limit for safe application of tobramycin powder topically, although, there have been case reports of acute renal failure after intrawound tobramycin administration. 2,15,20 The most significant limitations of this study are the retrospective design and small sample size inherent to infection research.…”
Section: Discussionmentioning
confidence: 99%